From 30^th to 31^st May 2023, the 4^th BIONNOVA Leaders Forum China 2023 is convened at Shanghai Marriott Hotel Parkview.

The Forum provides a platform of discussion over an array of issues including cell and gene therapy, antibody drugs, nucleic acid drugs & vaccines, clinical development & tumor immunology, small molecule drugs, investment & financing, innovation & collaboration, just to name a few. Wanhuida Intellectual Property is a co-sponsor of the Forum.

On May 30^th, the firm’s Partner Wang Rui speaks on “How could patent facilitate innovation of nucleic acid drugs” at the panel themed “Innovation of Nucleic Acid Drugs & Vaccines”. Ms. Wang shares with the attendees takeaways on leveraging patent application and search in fueling and protecting innovation as well as the cultivation of high-value patent in the nucleic acid pharmaceutical industry.

The firm’s Partner Hu Honghui and Patent Attorney Xie Chuanfang also attend the Forum.

Wang Rui speaking at the Forum